• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

AtheroNova Inc

+ Add to Watchlist

AHRO:US

0.3580 USD 0.0280 8.48%

As of 20:10:00 ET on 04/17/2014.

Snapshot for AtheroNova Inc (AHRO)

Open: 0.3700 Day's Range: 0.3580 - 0.3700 Volume: 17,600
Previous Close: 0.3300 52wk Range: 0.3100 - 0.7900 1-Yr Rtn: -40.33%

Stock Chart for AHRO

No chart data available.
  • AHRO:US 0.3660
  • 1D
  • 1M
  • 1Y
0.3300
Interactive AHRO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AHRO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1900
Est. EPS (USD) (12/2014) -0.1100
Est. PEG Ratio -
Market Cap (M USD) 14.89
Shares Outstanding (M) 41.58
30 Day Average Volume 47,448
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AHRO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AHRO

AtheroNova, Inc. researches treatments for clogged arteries. The Company researches natural compounds to regress arterial atherosclerotic plaque deposits.

Thomas W GardnerChairman/President/CEOMark SelawskiCFO/Secretary
Randolph M JohnsonChief Operating Officer
More Company Profile & Key Executives for AHRO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil